Home India Ministry of Health and Family Welfare Parliament Question: Treatment of Thalassemia under AB-PMJAY...
Date: 2025-08-08 Category: Not Applicable State: Union Government Country: India

Parliament Question: Treatment of Thalassemia under AB-PMJAY

Issued by Ministry of Health and Family Welfare · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Executive Summary: The Ministry of Health and Family Welfare addressed questions regarding the coverage of Thalassemia treatment, organ transplants, and cancer treatment under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (ABPMJAY). The scheme provides cashless health coverage of up to Rs. 5 lakh per eligible family per year for secondary and tertiary care hospitalizations. Data on hospital admissions and authorized amounts for these treatments were provided for the last three years. Key Points / Main Content: ABPMJAY Overview: * ABPMJAY provides cashless health coverage up to Rs. 5 lakh per eligible family per year. * It targets the bottom 40% of India's population, covering approximately 12 crore families. Thalassemia Treatment: * Treatment related to Thalassemia is covered under the HBP 2022 package master. * 1,18,171 hospital admissions related to Thalassemia treatment have been authorized under the scheme in the last three years. Organ Transplants: * HBP 2022 includes coverage for high-cost organ transplants like renal and bone marrow transplants. * As of June 30, 2025, 26,494 hospital admissions for transplant treatments have been authorized, amounting to Rs. 298.31 crore. Cancer Treatment: * Cancer treatment is provided through over 200 packages, covering more than 500 procedures (Medical, Surgical, Radiation Oncology, and Palliative Medicine). * State/UT-wise and year-wise details of hospital admissions for cancer treatment during the last three years are provided in the annexure. Impact Analysis: Citizens/Eligible Families: * Impact: Access to cashless treatment for Thalassemia, organ transplants, and cancer, up to Rs. 5 lakh per family per year. * Action Required: Understand the scheme's benefits and eligibility criteria to avail of the covered treatments. Hospitals/Healthcare Providers: * Impact: Increased patient volume and revenue through ABPMJAY-covered treatments. * Action Required: Ensure adherence to ABPMJAY guidelines for treatment and claim submission. Government (Ministry of Health and Family Welfare): * Impact: Monitoring and management of the ABPMJAY scheme, including budget allocation and program effectiveness. * Action Required: Continue to oversee the scheme's implementation and address any gaps or challenges in service delivery.

Key Entities Referenced

Ayushman Bharat Pradhan Mantri Jan Arogya Yojana: A flagship scheme of the Government of India that provides cashless health coverage of upto Rs. 5 lakh per eligible family per year for secondary and tertiary care hospitalizations. Thalassemia: A genetic blood disorder, the treatment and management of which is covered under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana. Health Benefit Package HBP 2022: A package under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana which includes coverage for high cost organ transplants such as renal and bone marrow transplants. Shri Gajendra Singh Patel: Member of Parliament who raised a question regarding treatment of Thalassemia under ABPMJAY. Shri Dinesh Bhai Makwana: Member of Parliament who raised a question regarding treatment of Thalassemia under ABPMJAY. Shri Bidyut Baran Mahato: Member of Parliament who raised a question regarding treatment of Thalassemia under ABPMJAY. Shri Prataprao Jadhav: Minister of State in the Ministry of Health and Family Welfare, who provided the answer to the Lok Sabha question. Andhra Pradesh: A state in India. State-wise details of number of hospital admissions related to the treatment of Cancer during last three years is provided in the annexure.
Official Source Record View Original Source →
See Full Document Text
GOVERNMENTOFINDIA MINISTRYOFHEALTH AND FAMILYWELFARE DEPARTMENTOFHEALTH ANDFAMILYWELFARE LOK SABHA UNSTARREDQUESTION NO. 3329 TOBE ANSWERED ON 08THAUGUST,2025 TREATMENTOFTHALASSEMIAUNDER AB-PMJAY †3329.SHRIGAJENDRASINGH PATEL: SHRIDINESHBHAI MAKWANA: SHRIBIDYUT BARANMAHATO: Will the Minister of HEALTHAND FAMILYWELFAREbe pleased tostate: (a) whether the treatment and management of Thalassemia is covered under Ayushman Bharat PradhanMantri Jan Arogya Yojana (AB PM-JAY), if so, the detailsthereof; (b) the number of children and adults availing thalassemia-related care under the scheme during the last three years; (c)whether benefitsare providedtopatients of Thalassemia underAyushman Bharat Pradhan Mantri Jan Arogya Yojana, if so, the detailsthereof; (d) whether there is any specific plan to provide special benefits to Thalassemia patients under the said scheme in aspirational and tribal districts of the county, if so, the details thereof; (e) whether AB PM-JAY covers complex and high-cost organ transplants such as bone marrow andkidneytransplants, if so, the details thereof; (f) the number of transplant procedures authorized and the amount disbursed so far under the scheme; (g) whether cancer is covered under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY); and (h) if so, the number of cancer treatments authorized and claims settled under AB PM-JAY during the last three years, State-wise andyear-wise? ANSWER THE MINISTER OFSTATEIN THE MINISTRYOFHEALTHAND FAMILYWELFARE (SHRIPRATAPRAOJADHAV) (a) to (d): Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is a flagship scheme of the Government of India that provides cashless health coverage of upto Rs. 5 lakh per eligible family per year for secondary and tertiary care hospitalizations to 12 crore families, constituting the bottom 40% of India’spopulation.Under AB-PMJAY, treatment related to Thalassemia is covered under HBP 2022 package master. A total number of 1,18,171 hospital admissions related to the treatment of Thalassemia have been authorizedunderthe scheme during the last three years. (e)and (f): UnderAB-PMJAY,HealthBenefitPackage(HBP)2022includescoverageforhigh -cost organ transplant such asrenaland bone marrow transplants. As on30.06.2025,a totalof 26,494 hospital admissions amounting to Rs. 298.31 crore has been authorized for transplant treatmentsunderthescheme. (g) and (h): Under AB-PMJAY, cancer related treatment is provided through more than 200 packages covering over 500 procedures of Medical Oncology, Surgical Oncology, Radiation Oncology and Palliative Medicine in the National Health Benefit Package (HBP) master. State/UT-wise andyear-wise detailsof numberof hospital admissions related tothe treatment ofCancerduringlastthreeyearsareatAnnexure.Annexure State/UT-wise andyear-wise detailsof numberof hospital admissions relatedtothe treatment of Cancerduring last three years State/UT 2022-2023 2023-2024 2024-2025 AndamanAndNicobarIslands 152 61 83 AndhraPradesh 2,80,016 3,39,957 3,76,859 ArunachalPradesh 104 197 430 Assam 19,373 72,104 787 Bihar 23,540 32,695 70,548 Chandigarh 374 594 852 Chhattisgarh 62,238 79,736 62,507 Dadra&NagarHaveliandDaman&Diu 1,274 1,491 1,692 Goa - - - Gujarat 2,54,415 3,41,636 2,88,062 Haryana 15,918 32,484 15,593 HimachalPradesh 5,083 4,569 2,106 JammuAndKashmir 42,705 45,572 47,436 Jharkhand 23,677 32,468 39,257 Karnataka 45,601 54,091 60,654 Kerala 1,05,486 1,10,846 72,662 Ladakh 439 316 206 Lakshadweep 33 37 93 MadhyaPradesh 1,53,112 1,71,631 1,72,159 Maharashtra 2,40,870 2,83,266 3,43,779 Manipur 3,569 4,697 1,145 Meghalaya 3,362 7,064 1,632 Mizoram 2,823 3,490 160 Nagaland 3,344 5,500 697 Puducherry 655 810 636 Punjab 35,817 46,832 7,052 Rajasthan 92,414 1,20,134 1,61,003 Sikkim 120 466 15 TamilNadu 1,54,100 1,55,212 1,51,260 Telangana 93,625 1,17,090 1,31,941 Tripura 3,945 5,300 803 UttarPradesh 72,666 1,32,828 1,96,834 Uttarakhand 21,145 24,585 5,802 *****

Continue your research